Accuray is a radiation oncology company that develops, manufactures, sells and supports treatment solutions for radiation therapy care. The company's technologies are: CyberKnife Systems, which automatically track, detect and correct for tumor and patient movement in real-time during the procedure, enabling delivery of high dose radiation with sub-millimeter accuracy while patients breathe normally, without manual user intervention; and TomoTherapy Systems, including the Radixact System, which represents a radiation therapy platform specifically designed for image-guided intensity-modulated radiation therapy. The company also provides its Onrad Treatment Delivery System in China.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.